Indocyanine Green Market
According to a new study by DataHorizzon Research, the Indocyanine Green (ICG) Market is projected to grow at a CAGR of 5.1% from 2025 to 2033, driven by increasing adoption of fluorescence imaging techniques in medical diagnostics and surgical procedures. Indocyanine green is a near-infrared fluorescent dye widely used for assessing hepatic function, cardiac output, and retinal angiography, as well as in intraoperative imaging during cancer, vascular, and reconstructive surgeries.
The growing prevalence of liver disorders, cardiovascular diseases, and cancer has accelerated the need for advanced diagnostic imaging agents. Additionally, the integration of ICG-based imaging with minimally invasive and robotic surgeries has significantly enhanced procedural precision, promoting its use in operating rooms worldwide. Technological innovations in fluorescence-guided surgery systems and rising awareness among healthcare professionals about ICG’s safety profile are expected to further drive market growth.
Market Size & Insights
The indocyanine green market was valued at approximately USD 127 million in 2024 and is anticipated to reach USD 198 million by 2033, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2025 to 2033, reflecting a strong growth trajectory fueled by rising demand across surgical imaging, diagnostics, and life sciences research. Indocyanine green is a vital component in fluorescence-guided imaging systems, enabling real-time visualization of blood vessels, lymph nodes, and tumor margins with exceptional accuracy.
Growing adoption of image-guided surgical procedures, particularly in oncology, cardiovascular surgery, and ophthalmology, has strengthened market demand. Hospitals and surgical centers are increasingly integrating ICG fluorescence imaging systems to improve visualization during complex procedures such as liver resection, coronary artery bypass, and lymphatic mapping.
Furthermore, the surge in clinical research applications using ICG as a tracer in drug delivery and tissue perfusion studies is expanding its scope beyond diagnostics. The market is also benefiting from favorable regulatory approvals and ongoing innovation in high-purity and stable ICG formulations that ensure better safety and efficacy. As healthcare infrastructure advances globally, particularly in emerging markets, the accessibility and utilization of ICG-based products are expected to grow substantially.
Get a free sample report: https://datahorizzonresearch.com/request-sample-pdf/indocyanine-green-market-54805
Important Points
• Rising use of indocyanine green in fluorescence-guided surgeries and diagnostic imaging.
• Increasing cases of liver, cardiovascular, and oncological diseases driving ICG adoption.
• Growing integration of near-infrared imaging systems in hospitals and surgical centers.
• Technological advancements improving dye stability, purity, and bioavailability.
• Expanding research on ICG’s use in drug tracking and biomedical imaging.
• Rising awareness of minimally invasive surgical procedures and precision diagnostics.
Key Factors Driving the Future Growth of the Indocyanine Green Market
• Technological Integration: Adoption of ICG-based fluorescence imaging in robotic and laparoscopic surgeries.
• Expanding Clinical Applications: Broadened use in cardiovascular diagnostics, oncology, and ophthalmology.
• Research and Innovation: Increasing R&D on novel ICG formulations for targeted imaging and photodynamic therapy.
• Growing Healthcare Expenditure: Rising investments in advanced diagnostic and surgical infrastructure.
• Regulatory Support: Approvals for ICG usage in newer medical and research applications.
• Emerging Markets Expansion: Rapid healthcare development in Asia-Pacific and Latin America fueling adoption.
Top 10 Market Companies
• Diagnostic Green GmbH
• FujiFilm Wako Pure Chemical Corporation
• Sigma-Aldrich (Merck KGaA)
• SERB Pharmaceuticals
• BioCare Medical
• PerkinElmer Inc.
• Akorn Pharmaceuticals
• Cardiovascular Systems Inc.
• GE Healthcare
• LI-COR Biosciences
Market Segments
By Type
• Medical Grade Indocyanine Green
• Industrial Grade Indocyanine Green
By Form
• Powder
• Solution
By Application
• Medical Diagnostics
• Cancer Detection & Imaging
• Cardiovascular Diagnostics
• Liver Function Assessment
• Others
By End-User
• Hospitals
• Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Others
By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Recent Developments
• Diagnostic Green GmbH launched a new high-purity ICG formulation optimized for near-infrared fluorescence imaging.
• FujiFilm Wako expanded its product line to include research-grade ICG dyes for molecular imaging studies.
• SERB Pharmaceuticals received regulatory clearance for an injectable ICG formulation for hepatic diagnostics in multiple regions.
• BioCare Medical introduced ICG-based imaging kits designed for clinical and research use.
• GE Healthcare partnered with surgical imaging companies to integrate ICG fluorescence in advanced imaging systems.
• PerkinElmer enhanced its fluorescence imaging instruments for preclinical ICG studies in oncology research.
Regional Insights
North America dominates the indocyanine green market, accounting for over 35% of global revenue, supported by high adoption in fluorescence-guided surgeries and extensive research applications. Europe follows closely, with countries like Germany, France, and the U.K. integrating ICG into advanced imaging systems. Asia-Pacific is projected to record the fastest growth, driven by rising healthcare investments, growing prevalence of liver and cancer diseases, and the expansion of surgical facilities in China, Japan, and India. Meanwhile, Latin America and the Middle East & Africa are emerging markets with growing adoption in hospitals and diagnostic centers.
Market Outlook
The outlook for the global indocyanine green market remains highly optimistic through 2033, as medical imaging and surgical precision continue to advance. With the global shift toward minimally invasive and image-guided surgeries, ICG is expected to play an increasingly critical role in real-time tissue visualization and perfusion assessment. The dye’s versatility across disciplines-from oncology and cardiovascular surgery to ophthalmology and hepatology-is ensuring its sustained demand in clinical practice.
In the coming years, technological convergence between AI-driven imaging systems and ICG fluorescence visualization will further revolutionize diagnostics and surgery. Research into ICG-conjugated nanoparticles and targeted imaging agents is opening new possibilities for precision medicine and theranostics.
However, challenges such as supply chain limitations, storage sensitivity, and high production costs of medical-grade ICG may temporarily hinder market expansion. Nonetheless, with rising healthcare accessibility, supportive regulations, and increasing investments in surgical technologies, the market is set to witness robust growth. By 2033, Indocyanine Green is expected to be integral to next-generation medical imaging and guided therapy systems, marking a new era of high-precision diagnostics and surgery.
Contact:
Ajay N
Ph: +1-970-633-3460
Latest Reports:
Smart And Interactive Textiles Market: https://datahorizzonresearch.com/smart-and-interactive-textiles-market-44927
Ct And X-Ray Inspection Equipment Market: https://datahorizzonresearch.com/ct-and-x-ray-inspection-equipment-market-45603
Coding Interview Platform Market: https://datahorizzonresearch.com/coding-interview-platform-market-46279
Bone Age Assessment Software Market: https://datahorizzonresearch.com/bone-age-assessment-software-market-46955
Company Name: DataHorizzon Research
Address: North Mason Street, Fort Collins,
Colorado, United States.
Mail: sales@datahorizzonresearch.com
DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.
This release was published on openPR.
